EVLO (Evelo Biosciences) 9-Day RSI: 41.19 (As of Jul. 01, 2026)


What is Evelo Biosciences 9-Day RSI?

Evelo Biosciences EVLO -99.00% 9-Day RSI is 41.19 as of Jul. 01, 2026.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-01), Evelo Biosciences's 9-Day RSI is 41.19.

The industry rank for Evelo Biosciences's 9-Day RSI or its related term are showing as below:

EVLO's 9-Day RSI is not ranked
in the Biotechnology industry.
Industry Median: 49.72 vs EVLO: 41.19

Evelo Biosciences  (OTCPK:EVLO) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

Evelo Biosciences 9-Day RSI Related Terms

EVLO vs IMNN, EDSA, TMBR: 9-Day RSI Comparison

For the Biotechnology subindustry, Evelo Biosciences's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evelo Biosciences 9-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evelo Biosciences's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Evelo Biosciences's 9-Day RSI falls into.


Evelo Biosciences  (OTCPK:EVLO) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 41.19 mean?
Evelo Biosciences (EVLO) has a 9-Day RSI of 41.19 as of Jul. 01, 2026.
Is Evelo Biosciences' 9-Day RSI too high?
Evelo Biosciences' current 9-Day RSI is 41.19. The Biotechnology industry median 9-Day RSI is 49.72. Evelo Biosciences' value of 41.19 is 17.2% below this industry median.
How does Evelo Biosciences' 9-Day RSI compare to IMNN and EDSA?
Evelo Biosciences' 9-Day RSI of 41.19 can be compared against companies in the Biotechnology industry. The industry median 9-Day RSI is 49.72. Evelo Biosciences' value of 41.19 is 17.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 49.72, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evelo Biosciences's current 9-Day RSI of 41.19 is 17.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 49.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evelo Biosciences's current 9-Day RSI is 41.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current 9-Day RSI of 41.19. The current 9-Day RSI is 41.19 and 17.2% below the Biotechnology industry median of 49.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current 9-Day RSI is 41.19 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.